» Articles » PMID: 10909851

Molecular Characterisation of 10 Dutch Properdin Type I Deficient Families: Mutation Analysis and X-inactivation Studies

Overview
Journal Eur J Hum Genet
Specialty Genetics
Date 2000 Jul 26
PMID 10909851
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Properdin type I deficiency is characterised by complete absence of extracellular properdin, a positive regulator of the alternative pathway of complement activation. Properdin deficiency is associated with increased susceptibility to severe meningococcal disease. We have identified the genetic defect in 10 Dutch families. Six different mutations and one sequence polymorphism in the properdin gene were found. All amino acid substitutions were limited to conserved amino acids in exons 7 and 8 in contrast to the premature stops that were found in other exons. The missense mutations may alter the protein conformation in such a way that properdin will not be secreted and therefore catabolised intracellularly. The decreased properdin levels found in some healthy females carrying one mutated properdin gene were studied for X-inactivation. Most carriers with extreme low or high properdin levels showed preferential X-inactivation for the normal or mutated X chromosome, respectively. We observed some exceptions, suggesting additional regulation of properdin excretion apart from X-inactivation.

Citing Articles

Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond.

Pedersen D, Lorentzen J, Andersen G Immunol Rev. 2022; 313(1):46-59.

PMID: 36097870 PMC: 10087229. DOI: 10.1111/imr.13129.


Human genetics of meningococcal infections.

Hodeib S, Herberg J, Levin M, Sancho-Shimizu V Hum Genet. 2020; 139(6-7):961-980.

PMID: 32067109 PMC: 7272491. DOI: 10.1007/s00439-020-02128-4.


Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.

Pedersen D, Gadeberg T, Thomas C, Wang Y, Joram N, Jensen R Front Immunol. 2019; 10:2007.

PMID: 31507604 PMC: 6713926. DOI: 10.3389/fimmu.2019.02007.


Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.

El Sissy C, Rosain J, Vieira-Martins P, Bordereau P, Gruber A, Devriese M Front Immunol. 2019; 10:1936.

PMID: 31440263 PMC: 6694794. DOI: 10.3389/fimmu.2019.01936.


The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?.

Michels M, Volokhina E, van de Kar N, van den Heuvel L Pediatr Nephrol. 2018; 34(8):1349-1367.

PMID: 30141176 PMC: 6579773. DOI: 10.1007/s00467-018-4042-z.